Implementation the Tripss Safeguards on Develop Country in Dealing with the H HIV/AID Epidemic
Abstract
The regulation of patent rights in TRIPSs is considered to be the cause of expensive drug prices due to its nature which gives exclusive rights to inventors or patent license holders to manufacture, use, offer and sell both products and processes. Nonetheless, TRIPSs actually regulates several models of flexibility over patents to protect the interests of developing countries. The provisions of the flexibility model in general actually aim to provide protection for public health in developing countries and can be used in the case of medicine. Indonesia as a TRIPSS participating country has the opportunity to take advantage of the flexibility model in drug-related patents. The author uses doctoral legal research or literature research with the issues discussed are how to implement the TRIPSs Safeguards in developing countries in overcoming the HIV/AIDS epidemic and how the TRIPSs provisions make use of cheap drugs in overcoming the HIV/AIDS epidemic in Indonesia. The result of the research is that the implementation of protective articles (The TRIPSs Safeguards) often leads to legal disputes among WTO members and issues of regulations in order to gain access to cheap drugs to overcome the HIV/AIDS epidemic.
References
Hidayati, Afif N. & Rosyid, A.N. dkk (Eds). 2019. Manajemen HIV/AIDS Terkini, Komprehensif, dan Multidisiplin. Surabaya: Airlangga University Press.
Mardliyana, Nova Elok dan Subhan Rullyansyah. 2022. Farmakologi Kebidanan. Malang: Penerbit Rena Cipta Mandiri.
Riswandi, Budi Agus dan M. Hawin. 2020. Isu-Isu Penting Hak Kekayaan Intelektual di Indonesia. Yogyakarta: Gadjah Mada University Press.
Sunendar, Iman, Eka An Aqimuddin dan Andre Dzulman. 2014. Pemanfaatan Model Fleksibilitas Paten Atas Obat Dalam WTO-Agreement On Trade Related Aspects Of Intellectual Property Rights (TRIPSS) Oleh Indonesia Ditinjau dari Undang-Undang Nomor. 14 Tahun 2001 Tentang Paten. Prosiding Seminar Nasional Penelitian dan PKM Sosial, Ekonomi dan Humaniora: ISSN 2089-3590, EISSN 2303-2472. Vol 4, No.1, Hal 91-98.
The TRIPSS Agreement and the Conventions referred to in it.
Tjay, Tan Hoan dan Kirana Rahardja. 2007. Obat-Obat Penting Kasiat, Penggunaan dan Efek-efek Sampingnya. Jakarta: PT Elex Media Komputindo.
Undang-Undang Nomor 13 Tahun 2016 tentang Paten.
Utomo, Tomi Suryo. 2007. Deklarasi Doha dalam Perspektif Akses Obat Murah dan Terjangkau: Sebuah Pelengkap Perjanjian TRIPSS. Vol. XXX, Hal 122-132.
Utomo, Tomi Suryo. 2008. Eksistensi “The TRIPSS Safeguards” di dalam Perjanjian TRIPSS dalam Perspektif Kesehatan Masyarakat. Volume 20, Hal 193-410.
Utomo, Tomi Suryo. 2009. Implementasi Lisensi Wajib Terhadap Produk Obat Yang Dipatenkan Pasca Deklarasi Doha: Jurnal Ilmu Hukum Refleksi Hukum Edisi April 2009, Hal 21-40.
Utomo, Tomi Suryo. Implikasi Pasal-Pasal Pelindung (The TRIPSS Safeguards) Dalam Undang-Undang Paten Indonesia: Kritik, Evaluasi dan Saran dari Perspektif Akses Terhadap Obat yang Murah dan Terjangkau. Volume 14, Hal 271-295.
Wesna, Putu Ayu Sriasih. 2020. Doha Declaration sebagai Perlindungan Masyarakat atas Akses Obat Esensial di Negara Berkembang Pasca TRIPSS Agreement. Sarana Komunikasi Dosen dan Mahasiswa Volume 14, Nomor I 2020 – CC-BY-SA 4.0 License, Hal 56-62.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright for this article is retained by the author(s), with first publication rights granted to the journal. This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (https://creativecommons.org/licenses/by-nc-nd/4.0/).
